Drug Approval | October 23, 2023
Natco Pharma receives 8 observations from USFDA for Pharma Division at Kothur
The company is confident of addressing all the observations within the stipulated time
The company is confident of addressing all the observations within the stipulated time
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Subscribe To Our Newsletter & Stay Updated
